Aptevo Therapeutics Inc. (APVO) vs Ernexa Therapeutics Inc. (ERNA)
A side-by-side comparison of Aptevo Therapeutics Inc. and Ernexa Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.83HealthcareDelayed quote: Oct 6, 2026, 12:42 PM EDT
ERNA
Ernexa Therapeutics Inc.
$2.38HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT
Total return — APVO vs ERNA
growth of $100 · dividends reinvested · last 10yAPVO -100.0% (-80.3%/yr)ERNA -100.0% (-65.1%/yr)ERNA compounded faster over this window
Log scale — wide-divergence pair
APVO ERNA
APVO vs ERNA: by the numbers
- •APVO is the larger company ($4M vs $4M market cap).
Metrics side by side
Valuation
| Metric | APVO | ERNA |
|---|---|---|
| P/B ratio | 0.66 | 1.21 |
Profitability
| Metric | APVO | ERNA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -437.15% | -383.03% |
| ROIC | -288.14% | -346.94% |
Growth (annualized)
| Metric | APVO | ERNA |
|---|---|---|
| Total return CAGR (5Y) | -95.30% | -86.83% |
Frequently asked
- How have APVO and ERNA total returns compared?
- Over the past 10 years, APVO delivered -80.35% and ERNA delivered -65.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.